Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston
3
×
boston blog main
boston top stories
eli lilly
life sciences
national blog main
san francisco blog main
san francisco top stories
avapritinib
biotech
blueprint medicines
deals
genentech
medullary thyroid cancer
national top stories
non-small cell lung cancer
pralsetinib
roche
selpercatinib
thyroid cancer
biontech
boehringer ingelheim
cancer
cancer drugs
capmatinib
clinical trials
cstone pharmaceuticals
curevac
europe blog main
europe top stories
european medicines agency
fda
fisogatinib
flatiron health
gastrointestinal stromal tumors
hepatocellular carcinoma
indiana blog main
indiana top stories
infectious diseases
investing
What
cancer
3
×
medicines
3
×
approval
blueprint
drug
fda
latest
ret
address
approves
bets
bio
candidate
carries
certain
comes
companies
currently
cut
date
deal
designed
effective
enticed
evidence
genetic
hasn’t
marketing
messenger
molecules
mrna
multiple
muscle
new
pact
pass
pharmaceutical
primarily
promise
proven
Language
unset
Current search:
medicines
×
boston
×
cancer
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
5 years ago
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines